Press release
Deadline on April 25th coming up in Lawsuit for Investors in Catalent, Inc. (NYSE: CTLT)

A Deadline is coming up on April 25, 2023 in the lawsuit for certain investors in Catalent, Inc. (NYSE: CTLT).
Investors who purchased shares of Catalent, Inc. (NYSE: CTLT) have certain options and there are strict and short deadlines running. Deadline: April 25, 2023. NYSE: CTLT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the the U.S. District Court for the District of New Jersey the plaintiff alleges on behalf of purchasers of Catalent, Inc. (NYSE: CTLT) common shares between August 30, 2021 and October 31, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between August 30, 2021 and October 31, 2022, statements made by the defendants were materially false and misleading when made because they misrepresented or failed to disclose the following adverse facts, which were known to Defendants or recklessly disregarded by them: (a) Catalent materially overstated its revenue and earnings by prematurely recognizing revenue in violation of U.S. Generally Accepted Accounting Principles ("GAAP"); (b) Catalent had material weaknesses in its internal control over financial reporting related to revenue recognition; (c) Catalent falsely represented demand for its products while it knowingly sold more product to its direct customers than could be sold to healthcare providers and end consumers; (d) Catalent disregarded regulatory rules at key production facilities in order to rapidly produce excess inventory that was used to pad the Company's financial results through premature revenue recognition in violation of GAAP and/or stuffing its direct customers with this excess inventory; and (e) as a result of the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company's financial performance, outlook, and regulatory compliance between August 30, 2021 and October 31, 2022.
Those who purchased shares of Catalent, Inc. (NYSE: CTLT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on April 25th coming up in Lawsuit for Investors in Catalent, Inc. (NYSE: CTLT) here
News-ID: 3008717 • Views: …
More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with shares of Revance Therapeutics, Inc …
An investor, who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC), filed a lawsuit over alleged violations of Federal Securities Laws by Revance Therapeutics, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, and / or those who purchased anyNASDAQ: RVNC shares prior to February 2024 and continue…

Lawsuit filed for Investors who lost money with shares of AstraZeneca PLC (NASDA …
An investor, who purchased shares of AstraZeneca PLC (NASDAQ: AZN), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by AstraZeneca PLC in connection with certain allegedly false and misleading statements made between February 23, 2022 and December 17, 2024.
Investors who purchased a significant amount of shares of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, have certain options and for certain…

Lawsuit filed for Investors who lost money with shares of Applied Therapeutics, …
An investor, who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT), filed a lawsuit over alleged violations of Federal Securities Laws by Applied Therapeutics, Inc.
Investors who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT) have certain options and for certain investors are short and strict deadlines running. Deadline: February 18, 2025. NASDAQ: APLT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
New York based Applied…

Investigation announced for Long-Term Investors in shares of WEBTOON Entertainme …
An investigation on behalf of current long-term investors in shares of WEBTOON Entertainment Inc. (NASDAQ: WBTN) concerning potential breaches of fiduciary duties by certain directors of WEBTOON Entertainment Inc. was announced.
Investors who are current long term investors in WEBTOON Entertainment Inc. (NASDAQ: WBTN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
More Releases for Catalent
Vaccine Contract Manufacturing Market is Growing Rapidly with Catalent, Moderna
Contract manufacturing is a complex process involved in producing vaccine products. This type of production usually involves the manufacturing of vaccines in a single step. Contract manufacturers usually produce vaccines at their facilities; however, some contract manufacturers also service the field through the provision of workspace and by taking care of the closing storage and final disposition of finished products. Some contract manufacturers specialize in the manufacture of one or…
Needlestick Safety Injection Devices Market: Top Players - Terumo, Unilife, Cata …
MarketResearchReports.Biz adds “Global Needlestick Safety Injection Devices Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Needlestick Safety Injection Devices and the growth estimates for the forecasted period.
This report studies the Needlestick Safety Injection Devices market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the…
Global Vegetable Capsules Market 2017-2023 Capsugel, Catalent, Qualicaps
Vegetable Capsules Market Research 2017
A market study "Global Vegetable Capsules Market" examines the performance of the Vegetable Capsules market 2017. It encloses an in-depth Research of the Vegetable Capsules market state and the competitive landscape globally. This report analyzes the potential of Vegetable Capsules market in the present and the future prospects from various angles in detail.
The Global Vegetable Capsules Market 2017 report includes Vegetable Capsules market Revenue, market Share,…
Global Vegetarian Capsules Market 2017 - Capsugel, Catalent, Qualicaps, SIRIO
Apex Research, recently published a detailed market research study focused on the "Vegetarian Capsules Market" across the global, regional and country level. The report provides 360° analysis of "Vegetarian Capsules Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Vegetarian Capsules industry, and estimates the future trend of Vegetarian Capsules market on…
Drug Delivery Devices Market 2017 - 3M, Cipla, Roche, Catalent, Allergan
Apex Research, recently published a detailed market research study focused on the "Drug Delivery Devices Market" across the global, regional and country level. The report provides 360° analysis of "Drug Delivery Devices Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Drug Delivery Devices industry, and estimates the future trend of Drug…
Global Capsule Shell Market 2017- Basf, Capsugel, Favea, Ijapbr, Catalent and Ca …
Global Capsule Shell Market 2017
The market study on Global Capsule Shell Market 2017 Research Report studies current as well as future aspects of the Capsule Shell Market primarily based upon factors on which the companies compete in the market, key trends and segmentation analysis. This report covers each side of the worldwide market, ranging from the fundamental market info and advancing more to varied important criteria, based on that, the…